Study of AVZO-021 in Patients With Advanced Solid Tumors
for Advanced Solid Tumor
Sites in New Haven +10 more locations
Sponsor: Avenzo Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05867251·Phase 1, Phase 2·Recruiting·Listed May 2023
Clinical Trials at Yale Cancer Center
As of September 2026, 67 paid clinical trials are recruiting at Yale Cancer Center, located at 333 CEDAR STREET, DEPARTMENT OF PEDIATRICS , 2073 LMP, NEW HAVEN, CT 06520-8064, phone (203) 785-4640 in New Haven, Connecticut. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
View the full facility profile →
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
67 clinical trials at Yale Cancer Center
·Clear filters· Get a weekly email when new trials open in New Haven, CT.
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
for Advanced Solid Tumor
Sites in New Haven +12 more locations
Sponsor: Volastra Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05902988·Phase 1, Phase 2·Recruiting·Listed Jun 2023
A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
for Higher-risk Myelodysplastic Syndromes
Sites in New Haven +13 more locations
Sponsor: Akeso
Sex: All·Age: 18+
Code: NCT06196203·Phase 2·Recruiting·Listed Jan 2024
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
for Pancreatic Cancer Metastatic
Sites in New Haven +8 more locations
Sponsor: Panbela Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05254171·Phase 2, Phase 3·Recruiting·Listed Feb 2022
A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab
for Advanced Solid Cancer
Sites in New Haven +3 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07607678·Phase 1·Recruiting·Listed May 2026
A Study of GEN1106 in Participants With Solid Tumors
for Solid Tumors
Drug: GEN1106
Sites in New Haven +4 more locations
Sponsor: Genmab
Sex: All·Age: 18+
Code: NCT07416123·Phase 1·Recruiting·Listed Feb 2026
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
for Non-small Cell Lung Cancer (NSCLC)
Sites in New Haven +8 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT07349537·Phase 1·Recruiting·Listed Jan 2026
A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors
for Advanced Solid Tumors
Sites in New Haven +4 more locations
Sponsor: Ottimo Pharma Limited
Sex: All·Age: 18+
Code: NCT07266428·Phase 1, Phase 2·Recruiting·Listed Dec 2025
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
for Advanced Solid Tumor
Sites in New Haven +6 more locations
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT07226349·Phase 1·Recruiting·Listed Nov 2025
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
for Breast Cancer
Sites in New Haven +5 more locations
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT07222267·Phase 1·Recruiting·Listed Oct 2025
M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors
for Advanced Solid Tumor
Sites in New Haven +2 more locations
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All·Age: 18+
Code: NCT07166601·Phase 1·Recruiting·Listed Sep 2025
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
for Advanced Prostate Cancer
Sites in New Haven +4 more locations
Sponsor: Genentech, Inc.
Sex: Male·Age: 18+
Code: NCT05800665·Phase 1·Recruiting·Listed Apr 2023
Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC
for Metastatic Non-Squamous Non-Small Cell Lung Cancer
Sites in New Haven +6 more locations
Sponsor: CatalYm GmbH
Sex: All·Age: 18+
Code: NCT07098988·Phase 2·Recruiting·Listed Aug 2025
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
for Advanced Solid Tumor
Sites in New Haven +4 more locations
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT06625593·Phase 1·Recruiting·Listed Oct 2024
Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer
for Head and Neck Cancer Squamous Cell Carcinoma
Sites in New Haven +1 more location
Sponsor: VSPharmTech Co.,Ltd.
Sex: All·Age: 18+
Code: NCT06959082·Phase 2·Recruiting·Listed May 2025
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
for CTCL
Sites in New Haven +5 more locations
Sponsor: Prescient Therapeutics, Ltd.
Sex: All·Age: 18+
Code: NCT06854653·Phase 2·Recruiting·Listed Mar 2025
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
for Advanced Adenocarcinoma
Sites in New Haven +8 more locations
Sponsor: BioAtla, Inc.
Sex: All·Age: 18+
Code: NCT05808634·Phase 1·Recruiting·Listed Apr 2023
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
for Cancer
Sites in New Haven +5 more locations
Sponsor: Simcha IL-18, Inc.
Sex: All·Age: 18+
Code: NCT04787042·Phase 1, Phase 2·Recruiting·Listed Mar 2021
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
for HER2-positive Metastatic Breast Cancer
Sites in New Haven, Guilford +35 more locations
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All·Age: 18+
Code: NCT06551116·Recruiting·Listed Aug 2024
Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma
for Follicular Lymphoma
Drug: Mosunetuzumab
Sites in New Haven +2 more locations
Sponsor: Brown University
Sex: All·Age: 18+
Code: NCT04792502·Phase 2·Recruiting·Listed Mar 2021
Optimizing Surgical Decisions in Young Adults With Breast Cancer
for Breast Cancer Stage 0
Sites in New Haven +3 more locations
Sponsor: Weill Medical College of Cornell University
Sex: Female·Age: 18 - 44
Code: NCT06275126·Recruiting·Listed Feb 2024
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
for Prostate Cancer
Drug: Relugolix
Sites in New Haven +3 more locations
Sponsor: Yale University
Sex: Male·Age: 18+
Code: NCT06111781·Phase 2·Recruiting·Listed Nov 2023
Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
for Metastatic Castration-resistant Prostate Cancer
1 location in New Haven
Sponsor: Yale University
Sex: All·Age: 18+
Code: NCT06100705·Phase 2·Recruiting·Listed Oct 2023
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
for Breast Neoplasms
Sites in New Haven +32 more locations
Sponsor: QuantumLeap Healthcare Collaborative
Sex: All·Age: 18+
Code: NCT01042379·Phase 2·Recruiting·Listed Jan 2010
Revumenib in Combination With 7+3 + Midostaurin in AML
for Acute Myeloid Leukemia
Drug: Revumenib
Sites in New Haven +1 more location
Sponsor: Richard Stone, MD
Sex: All·Age: 18 - 75
Code: NCT06313437·Phase 1·Recruiting·Listed Mar 2024
Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL
for PTCL
Sites in New Haven +5 more locations
Sponsor: University of Virginia
Sex: All·Age: 18+
Code: NCT04747236·Phase 2·Recruiting·Listed Feb 2021
Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns
for Metastatic Breast Cancer
Sites in New Haven +1 more location
Sponsor: Sun Yat-sen University
Sex: Female·Age: 18 - 80
Code: NCT06551220·Recruiting·Listed Aug 2024